Cover Image
市場調查報告書

骨生長刺激植入裝置:開發中產品分析

Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 333502
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
骨生長刺激植入裝置:開發中產品分析 Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年10月07日 內容資訊: 英文 70 Pages
簡介

在本報告提供全球各國的企業·醫療機關等正在開發的骨生長刺激植入裝置的開發中產品資訊相關分析,臨床實驗/產品開發的整體進展,及各階段·各地區·各領域的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發·資本交易的動向等資料為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 骨生長刺激植入裝置概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各地區
  • 開發中產品:法規各途徑
  • 開發中產品:認證各時期 (估計)
  • 現在進行中的臨床實驗

第4章 骨生長刺激植入裝置:正在開發的開發中產品 (各企業)

  • 骨生長刺激植入裝置的開發企業:各開發階段的開發中產品
  • 骨生長刺激植入裝置:各開發階段的開發中產品

第5章 骨生長刺激植入裝置的開發企業·產品概要

  • Histogenics Corporation:企業概要
    • 開發中產品及進行中的臨床實驗概要
  • REGENECURE, Ltd.:企業概要
  • Taxus Cardium Pharmaceuticals Group Inc.:企業概要
  • Tornier, Inc.:企業概要

第6章 骨生長刺激植入裝置:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0234EPD

GlobalData's Medical Devices sector report, "Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016" provides an overview of Bone Growth Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Growth Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Growth Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Growth Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Bone Growth Stimulators Overview

3. Products under Development

  • 3.1. Bone Growth Stimulators - Pipeline Products by Stage of Development
  • 3.2. Bone Growth Stimulators - Pipeline Products by Segment
  • 3.3. Bone Growth Stimulators - Pipeline Products by Territory
  • 3.4. Bone Growth Stimulators - Pipeline Products by Regulatory Path
  • 3.5. Bone Growth Stimulators - Pipeline Products by Estimated Approval Date

4. Bone Growth Stimulators - Pipeline Products under Development by Companies

  • 4.1. Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
  • 4.2. Bone Growth Stimulators - Pipeline Products by Stage of Development

5. Bone Growth Stimulators Companies and Product Overview

  • 5.1. Bionext Biotech Products Ltd. Company Overview
    • 5.1.1. Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Curative Biosciences, Inc. Company Overview
    • 5.2.1. Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Forticell Bioscience, Inc. Company Overview
    • 5.3.1. Forticell Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. GreenBone Ortho srl Company Overview
    • 5.4.1. GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Induce Biologics Inc. Company Overview
    • 5.5.1. Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. KeraCure, Inc. (Inactive) Company Overview
    • 5.6.1. KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Locate Therapeutics Limited Company Overview
    • 5.7.1. Locate Therapeutics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Osiris Therapeutics, Inc. Company Overview
    • 5.8.1. Osiris Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. OsteoGenix Incorporated (Inactive) Company Overview
    • 5.9.1. OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. REGENECURE, Ltd. Company Overview
    • 5.10.1. REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Scil Technology GmbH (Inactive) Company Overview
    • 5.11.1. Scil Technology GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Taxus Cardium Pharmaceuticals Group Inc. Company Overview
    • 5.12.1. Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Tornier, Inc. Company Overview
    • 5.13.1. Tornier, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Zimmer Biomet Holdings, Inc. Company Overview
    • 5.14.1. Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Bone Growth Stimulators- Recent Developments

  • 6.1. Sep 16, 2016: Osiris Provides Update Regarding NASDAQ Listing Status
  • 6.2. Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.3. Sep 14, 2016: Nanovis to Raises USD3.8 Million in Venture Financing
  • 6.4. Sep 13, 2016: Nanovis Raises USD1.1 Million in Venture Financing
  • 6.5. Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.6. Aug 16, 2016: NovaBone Products Receives GMP Medical Device Certificate
  • 6.7. Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results
  • 6.8. Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results
  • 6.9. Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results
  • 6.10. Jul 26, 2016: Globus Medical Reports Second Quarter 2016 Results
  • 6.11. Jul 21, 2016: Stryker reports second quarter 2016 results
  • 6.12. Jul 19, 2016: Bioventus Withdraws IPO
  • 6.13. Jul 06, 2016: Bone Biologics Names Scott D. Boden, MD Chief Medical Advisor
  • 6.14. Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.15. Jun 29, 2016: New chairman appointed at JRI Orthopaedics
  • 6.16. Jun 27, 2016: Greatbatch Renamed Integer Holdings
  • 6.17. Jun 24, 2016: Michael Minogue Named to Bioventus Board of Managers
  • 6.18. Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares
  • 6.19. Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes
  • 6.20. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.21. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.22. May 03, 2016: Globus Medical Reports First Quarter 2016 Results
  • 6.23. Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results
  • 6.24. Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results
  • 6.25. Feb 25, 2016: Orthofix Study Shows Pulsed Electromagnetic Field Therapy May Reduce Cellular Inflammation Associated with Disc Degeneration
  • 6.26. Feb 24, 2016: Globus Medical Reports Full Year and Fourth Quarter 2015 Results
  • 6.27. Jan 19, 2016: Globus Medical Announces Litigation Settlement Agreement
  • 6.28. Jan 12, 2016: Antibe Therapeutics Enters into Licensing Agreement with Induce Biologics
  • 6.29. Jan 11, 2016: Bioventus Board of Managers Appoints Bill Hawkins Chairman
  • 6.30. Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance
  • 6.31. Jan 06, 2016: Globus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales Results
  • 6.32. Dec 03, 2015: Cytos Biotech Merges with Kuros Biosurgery
  • 6.33. Dec 03, 2015: Cytos Biotechnology and Kuros Biosurgery to combine to create Kuros Biosciences
  • 6.34. Nov 11, 2015: Kuros Biosurgery Raises Additional USD5 Million Financing
  • 6.35. Nov 03, 2015: Globus Medical Reports Third Quarter 2015 Results
  • 6.36. Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results
  • 6.37. Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Bone Growth Stimulators - Pipeline Products by Stage of Development
  • Table 2: Bone Growth Stimulators - Pipeline Products by Segment
  • Table 3: Bone Growth Stimulators - Pipeline Products by Territory
  • Table 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path
  • Table 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
  • Table 6: Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
  • Table 7: Bone Growth Stimulators - Pipeline Products by Stage of Development
  • Table 8: Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Orthonext - Product Status
  • Table 10: Orthonext - Product Description
  • Table 11: Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Nurture BSP - Product Status
  • Table 13: Nurture BSP - Product Description
  • Table 14: Osteoconductive Scaffold - Product Status
  • Table 15: Osteoconductive Scaffold - Product Description
  • Table 16: Forticell Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Haptides Bone Regeneration - Product Status
  • Table 18: Haptides Bone Regeneration - Product Description
  • Table 19: GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: GreenBone Implant - Product Status
  • Table 21: GreenBone Implant - Product Description
  • Table 22: Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: URIST - Product Status
  • Table 24: URIST - Product Description
  • Table 25: KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: KeraPac - Bone Regeneration - Product Status
  • Table 27: KeraPac - Bone Regeneration - Product Description
  • Table 28: Locate Therapeutics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Injectable Bone Graft - Product Status
  • Table 30: Injectable Bone Graft - Product Description
  • Table 31: Osiris Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Osteocel XC - Product Status
  • Table 33: Osteocel XC - Product Description
  • Table 34: OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Bone Anabolic Agent - Product Status
  • Table 36: Bone Anabolic Agent - Product Description
  • Table 37: REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Regenecure AMCA GBR Bone Membrane Implant - Product Status
  • Table 39: Regenecure AMCA GBR Bone Membrane Implant - Product Description
  • Table 40: Scil Technology GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: ST03 Activated Implant - Product Status
  • Table 42: ST03 Activated Implant - Product Description
  • Table 43: ST04 Activated Injectable - Product Status
  • Table 44: ST04 Activated Injectable - Product Description
  • Table 45: ST05 - Product Status
  • Table 46: ST05 - Product Description
  • Table 47: Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Osteorate - Product Status
  • Table 49: Osteorate - Product Description
  • Table 50: Tornier, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Soft Tissue Graft - Product Status
  • Table 52: Soft Tissue Graft - Product Description
  • Table 53: Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: OrthoPak III - Product Status
  • Table 55: OrthoPak III - Product Description
  • Table 56: SpinalPak III - Product Status
  • Table 57: SpinalPak III - Product Description
  • Table 58: Glossary

List of Figures

  • Figure 1: Bone Growth Stimulators - Pipeline Products by Stage of Development
  • Figure 2: Bone Growth Stimulators - Pipeline Products by Segment
  • Figure 3: Bone Growth Stimulators - Pipeline Products by Territory
  • Figure 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path
  • Figure 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
Back to Top